Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...

Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and their reaction is trying to shut this ad down,” says a representative for ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

The Africa Centres for Disease Control and Prevention (Africa CDC) and African Union Development Agency - New Partnership for Africa's Development (AUDA-NEPAD) are proud to announce the signing of a ...

Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...

George Medicines appoints Amy Carroll as Senior Vice President of Medical AffairsLondon, UK, 3 February 2025 – George Medicines, a late-stage ...

Posos, InterSystems strengthen technological partnership to accelerate, secure AI-assisted drug prescription worldwideIssued by Anti-Clockwise Consulting for InterSystemsParis, 05 Feb 2025Visit our ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...

The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...